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The photostability and narrow emission spectra of nanometer-scale semiconductor crystallites (QDs) make them desirable
candidates for whole-mount ﬂuorescent in situ hybridization to detect mRNA transcripts in morphologically preserved intact
embryos. We describe a method for direct QD labeling of modiﬁed oligonucleotide probes through streptavidin-biotin and
antibody-mediated interactions (anti-FITC and anti-digoxigenin). To overcome permeability issues and allow QD conjugate
penetration, embryos were treated with proteinase K. The use of QDs dramatically increased sensitivity of whole-mount in situ
hybridization (WISH) in comparison with organic ﬂuorophores and enabled ﬂuorescent detection of speciﬁc transcripts within
cells without the use of enzymatic ampliﬁcation. Therefore, this method oﬀers signiﬁcant advantages both in terms of sensitivity,
as well as resolution. Speciﬁcally, the use of QDs alleviates issues of photostability and limited brightness plaguing organic
ﬂuorophores and allows ﬂuorescent imaging of cleared embryos. It also oﬀers new imaging possibilities, including intracellular
localization of mRNAs, simultaneous multiple-transcript detection, and visualization of mRNA expression patterns in 3D.
1.Introduction
With the advent of cell type speciﬁc molecular markers, des-
cription and analysis of developmental morphogenesis has
become possible in a number of biological systems. Gene-
speciﬁc RNA probes are now extensively used as they en-
able visualization of gene expression patterns and thus pro-
vide valuable information regarding the role of speciﬁc genes
during development, as well as regarding positioning and
movement of a particular cell type at diﬀerent stages of
development. This technique, known as whole mount in
situ hybridization (WISH), was initially performed using
radioactive probes, but was radically simpliﬁed when non-
radioactive probes were used successfully [2–4]. It is now
widelyusedinseveralbiologicalsystems,includingDrosophi-
la[4],X eno pus[5],quail[6],Dictyostelium[7],andZebraﬁsh
[8]. In situ hybridization (ISH) is a quite common technique
among developmental research labs, yet its uses are quite
diverse and include medical and prenatal diagnostics [9–
16]. Not long after its introduction, protocols using two
diﬀe r e n tl a b e l sf o rt h eR N Ap r o b e sa n dt w oc o l o rs u b s t r a t e s
were described, allowing the detection of more than one
transcript simultaneously [17]. However, a major limitation
of these chromogenic multilabeling techniques is that the
overlappingregionsofexpressionareverydiﬃculttodiscern.
The use of ﬂuorescent methods for detecting transcripts may
overcome this limitation; yet ﬂuorophores for single- as well
asdouble-transcriptvisualization[18]inwholemountshave
only been used extensively in the ﬂy and to some extent in
the zebraﬁsh [8]. More recently, simultaneous ﬂuorescent
detection of three transcripts was reported in the chick, and
multiplexing has been used to detect up to seven transcripts
in the ﬂy [19–21]. However, successful implementation of
current ﬂuorescent protocols is very rare, especially in the
mouse or Xenopus embryos, and even then the ﬂuorescent
images are of insuﬃcient quality and thus cannot rival the
staining obtained with normal chromogenic substrates.
In addition, imaging the signal is complicated due to
the strong autoﬂuorescence of the embryos [22], which
interferes with ﬂuorescent detection of RNA and makes2 Journal of Biomedicine and Biotechnology
the use of enzymatic ampliﬁcation necessary in the mouse,
Xenopus, chick, and other embryos. The ampliﬁcation step
is also necessary in the case of chromogenic protocols; how-
ever, this step undermines the resolving ability of both meth-
ods. Ampliﬁcation reactions create a precipitate which is
deposited in the area surrounding the RNA and then dif-
fuses out. It therefore does not remain localized within the
particular intracellular region or compartment where the
RNA in question is localized. In fact, it often diﬀuses
throughout the cell and sometimes even leaks outside of
the cell being labeled [23]. This problem is less pronounced
in the case of tyramide ampliﬁcation, where the peroxidase
reaction produces tyramide radicals that react covalently
with proteins at the site of the reaction, reducing the diﬀu-
sion radius appreciably [24, 25]. However, even in this case,
the resolution is still limited by diﬀusion and depends on the
time that the reaction is allowed to proceed [23]. To combat
diﬀusion issues, direct labeling of the probe is required, as
thisallowssinglecell,aswellas,intracellularresolutionofthe
localization of a particular mRNA. In addition to improved
resolution, direct labeling of the probe allows simultaneous
hybridization of multiple mRNAs, as long as ﬂuorophores
can be spectrally resolved. It is also extremely simple and
can be quantitative since the ﬂuorescence of the probe can be
calibrated [12]. Despite successful implementation of direct
labeling of messenger RNAs in cell culture [26, 27], this has
not been possible in embryos due to the low ﬂuorescent
intensities of organic ﬂuorophores.
The use of ﬂuorescent methods for detecting transcripts
is highly advantageous compared to chromogenic methods,
especially because it enables higher quality three-dimension-
al imaging, multiplexing diﬀerent RNA species, and covisu-
alization of RNA with proteins. As already mentioned, the
major limitations preventing widespread use of ﬂuorescence
detection for WISH are the high endogenous background
ﬂuorescence of many embryos, as well as the limited
brightness and photostability of organic ﬂuorophores. A
new type of inorganic ﬂuorophore, namely, Quantum Dots
(QDs) have been used recently in several systems in vitro for
detection of proteins as well as in vivo for protein labeling
and lineage tracing [28–42]. QDs were also used for in situ
hybridizationinclinicalbiopsiesforthedetectionofmultiple
mRNAs with successful conjugation to oligonucleotide
probes [43]. QDs have ideal optical properties for use in
biology like strong ﬂuorescent signal emission compared
to organic and protein ﬂuorophores [44, 45]. In addition,
due to their longer excited state lifetime, their ﬂuorescence
can be separated from the background ﬂuorescence with
time-domain imaging [46]. Using QDs oﬀers a number of
other advantages over organic ﬂuorophores including wide
excitation spectra (which makes the use of a single excitation
ﬁlter possible), narrow and tunable emission spectra (which
reduces spectral overlap making the simultaneous use of
more colors possible), large separation between the excita-
tion and emission (which increases the detection sensi-
tivity), and resistance to photobleaching [47, 48]. Their
unique optical properties made QDs an ideal candidate for
detecting multiple mRNAs in ISH protocols [49], and their
high ﬂuorescence intensity raised the possibility of using
them for RNA detection in whole embryos. Previous ef-
forts to do this met with aggregation issues and were time
consuming since detection had to be done with RNA
covalently linked to hydroxylated QDs [50]. Since then, we
and others have reported new methods of creating hydro-
philic QDs and hydrophilic QD conjugates have become
commercially available [32, 38, 51]. Studies have also
pointed out diﬃculties in using QDs for FISH experiments
[52, 53], including steric hindrance [54], degradation of QD
conjugates and adherence to tubes and tips [55].
In this work we explore the use of QDs in WISH ex-
periments. We show that the greatest limitation of these
nanocrystals is penetration, since commercially available
QDs are quite large and therefore fail to penetrate the
many cell layers of an embryo or are signiﬁcantly trapped
if they do. However, we have determined that proteinase
Kc a nr e n d e rXenopus embryos suﬃciently permeable to
allow QD penetration deep within embryonic tissues. More
speciﬁcally, we produced ﬂuorescein- (FITC-), biotin- , and
digoxigenin (DIG) labeled RNA probes and used QD-
antibody and QD-streptavidin conjugates to visualize them.
Our experiments show that this is an extremely sensitive
assay that signiﬁcantly improved RNA detection sensitivity.
We then employed QDs to visualize several RNA probes that
had been used to perform WISH in Xenopus embryos. We
demonstrate that QD detection of endogenous messenger
RNAs is eﬀective and that it can be used to provide WISH
data of higher resolution than current techniques. Finally,
we show that QDs can be used to carry out two-color in
situ hybridization simultaneously. Therefore, the use of QDs
to perform nonampliﬁed ﬂuorescent whole mounti ns i t u s
in Xenopus embryos, one of the most highly autoﬂuorescent
(and thus demanding) vertebrate developmental organisms,
suggests that QD whole-mount in situs will ﬁnd successful
applications in most developmental models.
2.MaterialsandMethods
2.1. Embryos. Xenopus laevis embryos from induced spawn-
ing [56] were staged according to Nieuwkoop and Faber
[57]. Operation techniques and buﬀer (MMR) have been
described [56]. Xenopus embryos were fertilized in vitro and
dejellied using 2% cysteine-HCl, pH 7.8, then maintained in
0.1X Marc’s Modiﬁed Ringer’s (MMR).
2.2. Whole-Mount Immunoﬂuorescence. Xenopus laevis em-
bryos were ﬁxed in 3.7% formaldehyde in MEMFA (2 hours
at room temperature), and the vitelline envelope was man-
ually removed with forceps. Permeabilization of embryos
was carried out several ways: (1) overnight in 1X PBS
supplemented with 0.5% Triton, and 1% DMSO (PBDT),
(2) overnight in 1X PBS supplemented with 5% Triton and
1% DMSO, (3) two hours in 1X PBS supplemented with
0.2% SDS, and (4) for four hours in 1X PBS supplemented
with 0.2% SDS or (5) for 25 minutes in 10¯g/mL Proteinase
K. Embryos were then blocked for 2 hours in 1X PBS with
0.5% Triton, 5% BSA, and 1% Normal Goat serum. Primary
antibody staining followed. Embryos were incubated withJournal of Biomedicine and Biotechnology 3
biotin-conjugated phosphotyrosine (anti-4G10, Millipore)
antibody overnight at 4◦C at a dilution of 1:500 (in block
solution). Embryos were then washed (3 × 10min) in PBDT
and incubated for 2 hours at room temperature with strep-
tavidin conjugated Cy3 or QDs 655nm at 1:500 dilution in
fresh block solution. After incubation, embryos were washed
in PBDT (3 × 10min). For negative control experiments,
embryos were blocked and then incubated with secondary
conjugates only. Clearing of embryos was performed by
immersion of the embryos in two parts benzyl benzoate
and one part benzyl alcohol after methanol dehydration
(Murray’s Clearing Medium, BB:BA). The refractive index
of BB:BA closely matches the refractive index of yolk
thereby rendering Xenopus embryos nearly transparent. The
embryos were imaged on a Zeiss Axio Imager Z1 using a
Zeiss Axiocam MR3, the Axiovision software 4.7. Optical
sectioning was achieved using a Zeiss Apotome structured
illumination system.
2.3. In Vitro Transcription. Antisense digoxigenin - (DIG-),
biotin- , and ﬂuorescein - (FITC-) labeled Xbra (in CS2++),
Edd, MyoD (in CS2++), Amylase (in pCR4Blunt-TOPO),
Xa-1 (in pBSK+), cardiac actin (in pSP64), and LTBP1 (in
CS2++) probes were synthesized by in vitro transcription
from linearized plasmid using RNA polymerase SP6 or T3
and ribonucleotide mixture which results in RNA transcripts
containing bio-UTP, FITC-UTP, or Dig-UTP (Roche). The
manufacturer’s protocol was followed with a modiﬁcation
in the total reaction volume which was scaled down to
20μL. RNA probes from these reactions was puriﬁed using
isopropanol/LiCl precipitation.
2.4. Chromogenic and Fluorescent Wholemount In Situ Hybri-
dization. Biotin-, FITC-, and DIG-labeled RNA probes
(transcribed as described above) were used to perform in
situ hybridization using the protocol reported by Harland
[58].withsomemodiﬁcation.Methanolwassubstitutedwith
ethanol and 4% paraformaldehyde in PBS was used to ﬁx the
embryos instead of formaldehyde. After proteinase K treat-
ment(5minforchromogenicWISHand25minutesforQD-
based WISH) embryos were blocked with 0.1% BSA, 10%
sheep serum in 0.1% Tween in 1 X PBS(PBT) solution, and
thenwasheswereperformedinPBS.Afterblocking,embryos
were reﬁxed for one hour in 4% paraformaldehyde followed
by prehybridization at 65◦C. For chromogenic WISH exper-
iments, the original protocol was followed. However, for
QD-based ﬂuorescent WISH experiments the protocol was
modiﬁed. After the last 0.2X SSC wash at 65◦C the embryos
w e r eb l o c k e dw i t h1XP B S+0 . 1 %B S A+0 . 1 %T w e e nf o r
one hour and then transferred to a new vial which contained
1mL of a 1:500 dilution Qdot-streptavidin 705nm, QD-
anti-FITC or QD-anti-DIG 655nm (Invitrogen) conjugates
in blocking solution. The addition of 0.1% BSA and 0.1%
Tween into the incubation buﬀer signiﬁcantly improved
penetration and decreased background without appreciably
aﬀecting the QD colloidal stability or the signal intensity.
After the incubation, the embryos were washed in PBT (4 ×
30min) at room temperature. Embryos were then cleared in
BB:BA (as described above). The ﬂuorescent signal remains
localized after clearing, and this allows data acquisition from
diﬀerent planes within the embryo without the need for
sectioning. The embryos were imaged on an upright Zeiss
ﬂuorescent microscope with a Zeiss Axiocam and the Axio-
vision 4.7 software (using a custom ﬁlter set; excitation 300–
460nm, emission 500nm longpass, dichroic 475nm). When
detectingweaksignals,theAxiovisionsoftwareallowedwhite
balancingofthecamerasothatthatthegreenbackground(in
embryos viewed with a 420 long pass ﬁlter due to the bias of
the autoﬂuorescence towards shorter wavelengths) appears
white, resulting in a major boost of the QD signal (605
peak emission), decrease of the threshold of detection and
signiﬁcantly better contrast. If the calibration of the camera
is done properly, control embryos that are not labeled with
QDs appear completely white under UV excitation without
any traces of red. This color separation method has to be
performed carefully and control embryos need to appear
white otherwise the risk of generating false staining increases
signiﬁcantly. Due to the fact that the embryo has several
distinct regions where the background ﬂuorescence changes
not only in terms of intensity but also in terms of spectral
balance the region chosen for assignment of “white” was
the region in which the background had the longest average
wavelength. In this manner we ensured that long-average
wavelength background regions would appear white, and
shorter average wavelength regions would appear blue.
3. Results and Discussion
3.1. Proteinase K Facilitates QD Penetration in Xenopus Em-
bryos. We ﬁrst wanted to examine whether QDs could pene-
trateXenopus embryostoasuﬃcientdepthsoastoallowspe-
ciﬁc deep tissue staining. We initially compared streptavidin-
conjugated QDs to streptavidin-conjugated Cy3 in whole-
mount immunostaining experiments for their ability to
detect a biotinylated antibody against phosphotyrosine. This
antibodywaspurposelyselectedduetoitsstrongandspeciﬁc
staining pattern of cell-cell boundaries that allows easy visual
conﬁrmation upon successful labeling. Not surprisingly, the
staining pattern obtained using QDs was very similar to
the one obtained using Cy3 in the superﬁcial cell layer of
the embryo (upper area of Figure 1(a) showing superﬁcial
cells of the ﬁn of a tadpole and data not shown). However,
and in contrast to Cy3, QD staining could not be detected
beyond the ﬁrst cell layer indicating that QDs encountered
penetration issues, most likely due to size restrictions
(Figure 1(a) lower area showing the somites of the tadpole).
Several approaches were employed to increase QD embryo
permeability, including the use of harsh detergents like SDS,
with limited success. However, use of proteinase K treatment
enabled penetration of QDs into deep tissues and resulted
in speciﬁc deep tissue staining (Figure 1(b) and Table 1).
However, proteinase K treatment is not suitable for use with
most whole-mount immunostaining antibodies as it may
lead to degradation of the target antigen.
It should be noted that the best results were obtained
using newly opened QD-streptavidin conjugates from Invit-
rogen. Unfortunately though, the performance of these4 Journal of Biomedicine and Biotechnology
(a) (b) (c)
100µm
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Figure 1: Proteinase K treatment is necessary to allow QD penetration and labeling of deep tissues in Xenopus and QD705nm anti-Dig
conjugates can be used for the detection of transcripts in wholemount in situ hybridization experiments. (a) Detection of biotinylated 4G10
(anti-Phosphotyrosine) antibody using streptavidin conjugated 655nm QDs in a triton permeabilized embryo. Speciﬁc staining can be seen
at the cell-cell boundaries of the ectodermal cells of the ﬁn (upper part of the image) but not in the deep tissues (somites at the bottom
part of the image). (b) Detection of biotinylated 4G10 (anti-Phosphotyrosine) antibody using streptavidin conjugated 655nm QDs in a PK
permeabilized embryo. Speciﬁc staining of the deep intersomitic boundaries can be seen. Superﬁcial cells of the ﬁn cannot be seen due to
degradation of this delicate structure by the PK treatment. (c) QD705nm anti-DIG antibody labeling of the probe for LTBP1 generates a
staining pattern that closely matches the published expression for this mRNA [1]. QDs label the somites as well as anterior neural and neural
crest tissues including the branchial arches and a region surrounding the eye. (d) Imaging of the QD labeling for LTBP1 in the somites at
10X magniﬁcation.
Table 1: Comparative chart of diﬀerent permeabilization ap-
proaches used in whole mount immunostaining using a biotinyla-
ted anti-phosphotyrosine antibody (4G10 clone) and detected with
StreptavidinconjugatedQDs.ProteinaseKtreatmentistheonlyap-
proach which allowed deep tissue staining using QDs.
Superﬁcial Staining Deep Tissue Staining
TRITON 1% +++ −
TRITON 5% +++ −
0.2% SDS 2h +++ +
0.2% SDS 4h +++ +
PK 25min +++ +++
conjugateswasbatchdependentandsigniﬁcantlydiminished
if QD-streptavidin conjugates were stored for more than
two-three months, despite a six-month shelf life stated by
the manufacturer. In addition, it was evident that use of
QDs with emissions in the NIR (700 and 800nm) provided a
big improvement in detection sensitivity due to a signiﬁcant
reduction of tissue autoﬂuorescence in this region of the
spectrum. However, commercially available QDs with peak
emissionsinthesewavelengthsarequitelargeandsuﬀerfrom
even greater permeability problems. Consequently, there is
an increased need for more reliable and smaller NIR QDs to
become commercially available.
3.2. QD Labeling of LTBP1 in Xenopus Embryos. Given that
proteinase K treatment facilitated QD penetration in Xeno-
pus embryos and allowed speciﬁc deep tissue staining in
whole-mount immunostaining experiments, we wanted to
determine whether QDs could be used in WISH experiments
in which proteinase K treatment is a standard permeabiliza-
tion approach. We initially tested whether anti-digoxigenin-
conjugated QDs could detect a DIG-labeled RNA probe spe-
ciﬁcforXenopus LatentTransformingGrowthFactorβ Bind-
ing Protein 1 (LTBP1). As shown in Figure 1, anti-DIG QDs
(see Figures 1(c) and 1(d)) gave a similar staining pattern
of Xenopus LTBP1 to the published pattern obtained using
the same probe but developed using a chromogenic reaction
[1]. LTBP1 signal was detected in the head region including
branchial arches and around the eye (shown as inset of
Figure 1(c))andthesomitesinagreementwiththepublished
expression pattern [1]. Furthermore, QD-labeling of LTBP1Journal of Biomedicine and Biotechnology 5
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Figure2:QD-streptavidinstainingofLTBP1comparesfavorablywiththepublishedstainingachievedusingstandardchromogenicprotocols
in the deeper structures of the embryo [1]. (a) A transverse section from a whole mount in situ indicating the LTBP1 transcript expression
pattern using QD705nm streptavidin. The somitic staining obtained using QDs is identical to the published data using the chromogenic
protocol[1],showingthattheQD-streptavidinsolutioncanpenetrateandstainthedeepareasofthesomites.(b)Aseriesoftransverseoptical
sections of a QD-streptavidin-stained embryo for the LTBP1 message. The optical sections reveal that the staining previously identiﬁed as
notochord by the chromogenic protocol is in fact somitic mesoderm ﬂanking the notochord (nc: notochord, sm: somatic mesoderm).
exhibited high signal intensity and resolution conﬁrming
that a regular ﬂuorescence microscope is suﬃcient for detec-
tion (see Figures 1(c) and 1(d). To further establish that
the QD in situ protocol is capable of successful and speciﬁc
staining,wesectionedandimagedwhole-mountQD-stained
embryos. As shown in Figure 2(a),Q D sc a np e n e t r a t ed e e p
into the embryo following proteinase K treatment and stain
structures independently of their proximity to the free QDs
in solution. Importantly, the use of QDs for in situ staining
could result in more accurate determination of transcript
expression patterns. Figure 2(b) shows a series of optical sec-
tion images taken from a z-stack movie, using a ﬂuorescence
microscope, starting at the head region and moving posteri-
orly. As indicated, QD labeling survives the clearing protocol
used to render Xenopus and other embryos transparent.
More importantly, however, is that the optical sections
demonstrate that the staining does not originate from the
notochord as originally published [1], but rather from the
somitic mesoderm ﬂanking the notochord. Therefore, the
additional spatial cues provided by optical sectioning can
lead to a more accurate determination of an expression
domain, further emphasizing the advantages of QD in situs.
3.3. QD Labeling of Speciﬁc Transcripts in Xenopus Embryos.
The above results suggest that use of anti-DIG conjugated
QDsinWISHcangivehighlyspeciﬁcstainingofDIGlabeled
mRNAprobes, evenindeep tissues.To furtherdetermine the
utility of this approach we tested whether QDs could also
label alternative modiﬁed oligonucleotide probes through
biotin-streptavidin and FITC- anti-FITC interactions, using
a similar protocol. Figure 3(a) depicts in situ staining per-
formed on a dissected Xenopus tadpole gut, against a biotin
labeled amylase probe using either streptavidin-conjugated
QDs or the chromogenic reaction. It is evident, from the
images, that similar staining patterns are obtained; both
the QDs and the chromogenic staining were restricted to
the pancreas, where amylase RNA is expressed. Non-stained
areas appear white due to background ﬂuorescence that is
present in all visible wavelengths. Despite high background,
we obtained a good signal to noise ratio (suﬃcient to allow
clear visualization and delineation of the expressing region)
and excellent contrast in the most highly autoﬂuorescent
organ of the Xenopus tadpole.
Wewentontotestthreewell-knownmRNAs,namely,(a)
Endodermin (Edd: a pan-endodermal marker), (b) Xbra (an
early mesodermal marker), and (c) MyoD (a gene encoding
a DNA-binding protein that can activate muscle gene expres-
sion), which stain the gut, the mesodermal belt, and the
musclesomites,respectively.AsindicatedinFigures3(b)and
3(d), the use of QDs in in situs gives staining patterns that
closely match the ones obtained using standard enzymati-
cally ampliﬁed chromogenic reaction methods, while main-
taining high resolution. The degree of resolution, however,
varieswiththetranscriptofinterestanditsrespectiveexpres-
sion pattern. For example, in the case of MyoD (Figure 3(b),
FITC-labeled probe used), the posterior somites look fused
when using the chromogenic protocol but are clearly distinct
when using QDs. In contrast, QD staining of a biotin-
labeled probe against Edd, which is expressed in the highly
autoﬂuorescent gut appears weak except at the anterior,
where the gene is expressed at higher levels (Figure 3(c)).
Alternatively, in the case of Xbra (Figure 3(d)), the staining
ofthechromogenicandtheQD(againstbiotin-labeledprobe
against Xbra) in situ is almost identical. Hoechst was used
to counter-stain the nuclei blue in this experiment, and the
cleared embryo was visualized from the animal pole.
3.4. Simultaneous Labeling of Two Transcripts Using QDs.
The fact that all three common modiﬁcations of RNA probes
couldbe detected successfullywithQDs raisedthe possibility
that QDs could be used to detect two or more transcripts
simultaneously. Achieving multiple transcript labeling using
chromogenicprotocolsisatimeconsuming,stepwiseprocess
which, as explained earlier, results in the inability to distin-
guish areas of coexpression. In order to determine whether
twotranscriptscanbevisualizedsimultaneously,withtheuse6 Journal of Biomedicine and Biotechnology
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Figure 3: In situ hybridization using QDs compares favorably
with chromogenic in situ hybridization staining for a number of
well-characterizedmRNAs.(a)705nmQD-streptavidinstainingfor
amylase on dissected Xenopus guts, using a biotinylated amylase
probe, is compared to the staining obtained by chromogenic
reaction (left). The staining using QDs is identical to that using
a chromogenic reaction and restricted to the pancreas, where
amylase mRNA is expressed. It is worth noting that the pancreas,
a morphologically identiﬁable organ, is extremely autoﬂuorescent
making detection of ﬂuorescent staining diﬃcult. (b) Comparison
of the QD and chromogenic staining for MyoD a muscle marker
(using a FITC-labeled probe). The 655nmQD anti-FITC and the
chromogenic staining are similar, but the QD staining gives much
better resolution of the posterior somites. (c) Comparison of QD
versus chromogenic staining for the Edd transcript, an endodermal
marker expressed through the tadpoles gut at varying levels (using
a Biotin-labeled probe). The staining using a chromogenic protocol
is signiﬁcantly stronger in this case and the 705nmQD-Streptavidin
seems restricted to the high expression regions. Careful observation
reveals that the staining is present throughout the gut region but is
masked by the intense autoﬂuorescence of the gut. (d) Comparison
of the QD staining versus the chromogenic staining for Xbra, a
widely used mesodermal marker (using a Biotin-labeled probe).
Themarkerisknowntolabelthemesodermalbeltatgastrulastages;
both the chromogenic, as well as the QD-streptavidin protocols
result in the same staining pattern consistent with the mesodermal
belt.
of QDs, we generated two probes; a FITC-labeled probe
against Xa-1 and a biotin-labeled probe against Xenopus car-
diac actin. The two probes were hybridized at the same time
and detected using spectrally distinguishable anti-FITC-con-
jugated and Streptavidin-conjugated QDs, respectively. As
seen in Figures 4(a) and 4(b) both probes were visualized
successfully demonstrating the ability of simultaneous detec-
tion of multiple transcripts using the QD in situ protocol.
In addition, due to the lack of enzymatic ampliﬁcation,
the resolving ability of this method is substantially better
than that of ampliﬁed protocols. This is evident in Figures
4(c) and 4(d), where we present high-magniﬁcation images
of whole-mount-stained embryos showing the intracellular
mRNA localization for Xa-1 and LTBP1, respectively. As can
be seen, QD labeling of transcripts is of extremely high res-
olution and enables distinction of intracellular localization
patterns of mRNA. While LTBP1 localized in the cytoplasm,
the Xa-1 transcript appeared to be concentrated near the
plasma membrane at the cell-cell contact areas. Even though
there is no evidence proving that the presented mRNA
distribution coincides with the true intracellular localization
of these transcripts, the fact that there are such dramatic
diﬀerences in the signal patterns from diﬀerent probes
suggests that this is indeed the case. Future work will have
to focus on closely examining the resolution of this method
in model systems where direct, nonampliﬁed in situs can be
performed, using traditional ﬂuorophores for comparison.
Nevertheless, it is clear that this level of resolution cannot
be achieved with existing methods for RNA transcript
detection in Xenopus, which are mostly based on enzymatic
ampliﬁcation. We thus propose that use of the QD approach
can simultaneously give macroscopic and intracellular data
regarding the distribution of mRNAs in vertebrate embryos.
4. Conclusions
Herein we describe a new application of QDs in nonampli-
ﬁed whole-mount ﬂuorescent in situ detection of endoge-
nous mRNAs. The ideal optical properties of QDs provide
unprecedented resolution and strong signal intensities that
have not been possible to attain using traditional ﬂuoro-
phores. In fact, even though WISH has been available for
more than a decade, the requirement for an enzymatic
ampliﬁcation step signiﬁcantly limited the resolution of
this method. Additionally, limitations of current ﬂuorescent
protocols have prevented widespread use of ﬂuorescent in
situs in most developmental models, with the exception of
Drosophila, and to some extent zebraﬁsh; direct visualization
of highly abundant transcripts is possible in Drosophila,
but not in most vertebrate models, in which an enzymatic
ampliﬁcation step is required. Fluorescent detection of a
messenger RNA opens exciting possibilities in terms of
imaging and can eliminate the need for sectioning samples.
Optical sectioning provides better spatial cues and ensures
correct identiﬁcation of expression domains. It can also be
used to create three-dimensional maps of expression, at a
previously unattainable resolution, especially if the ampliﬁ-
cation step is eliminated. Intracellular localization of mRNA
transcripts has only recently been investigated [59–63]. The
study of mRNA localization is limited by the current in
situ methods, both ﬂuorescent and chromogenic, due to
their relatively low resolving ability. Chromogenic reactions
have been used successfully to localize mRNA transcripts in
cultured cells but only for transcripts of very high abundance
[60–63]. The method we describe is the ﬁrst nonampliﬁed
ﬂuorescent detection of mRNA in situ in Xenopus.O u r
protocol results in signal intensities suﬃcient for imaging
on a regular epiﬂuorescence microscope without the needJournal of Biomedicine and Biotechnology 7
(a) (b)
20µm
(c) (d)
Figure 4: Double whole-mount in situ hybridization against cardiac actin and Xa-1 and the intracellular distribution of LTBP1 and Xa1. (a)
A comparison of the staining pattern between the chromogenic and QD-based visualization of the FITC-labeled Xa-1 probe, shown in red,
reveals that the QD staining is identical to that obtained using the standard chromogenic protocol. (b) An embryo processed using Biotin
and FITC-labeled probes against cardiac actin (green) and Xa-1 (red), respectively. The two probes were visualized with spectrally resolvable
QDs demonstrating that two color ﬂuorescent in situs can be performed using QDs. The inset shows the chromogenic staining for cardiac
actin for comparison. (c, d) Images of embryos processed for whole-mount in situ hybridization and counterstained with Hoechst (blue) at
20X (c) and 40X (d) magniﬁcation, showing diﬀerences in the intracellular distribution of the transcripts of Xa-1 (c) and LTBP1 (d), both
s h o w ni nr e d .
for confocal microscopy. Of great signiﬁcance, in terms of
Xenopus and other opaque embryos like the chick, is the fact
that the QD in situ staining is capable of remaining localized
and ﬂuorescent for more than an hour after the embryo is
cleared. QD in situs also oﬀer the potential for intracellular
resolution of mRNA expression. This has not been possible
usingtraditionalchromogenicorﬂuorescentmethods.Inthe
case of C. elegans, where background is not a major issue, use
of ﬂuorescent antibodies to detect labeled RNA probes has to
be carried out in conjunction with chromogenic ampliﬁed
detection of the probes in order to get a comprehensive
picture of the overall expression of a gene [64]. The ampli-
ﬁed reaction detects low expressing regions and overall
expression, whereas the ﬂuorescent antibodies are used to
resolve intracellular localization. The fact that our QD in situ
protocol can do both in the highly autoﬂuorescent Xenopus
embryo, which is highly demanding, makes us conﬁdent that
the implementation of QD in situs in other less demanding
model systems will be met with equal or more success.
More importantly, these results suggest that QDs could be
introduced asalternative ﬂuorophoresin otherﬂuorescentin
situ hybridization assays where their spectral properties can
oﬀer signiﬁcant advantages. Overall, our results demonstrate
that QD in situs are a viable alternative to current ISH
protocols, and they expand the uses of QDs in biology.
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